Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-9.02%
operating margin TTM
-9.5%
revenue TTM
44.07 Million
revenue per share TTM
1.02$
valuation ratios | |
|---|---|
| pe ratio | -53.98 |
| peg ratio | -0.53 |
| price to book ratio | 7.47 |
| price to sales ratio | 4.88 |
| enterprise value multiple | -68.56 |
| price fair value | 7.47 |
profitability ratios | |
|---|---|
| gross profit margin | 90.44% |
| operating profit margin | -9.5% |
| pretax profit margin | -9.07% |
| net profit margin | -9.02% |
| return on assets | -8.31% |
| return on equity | -14.19% |
| return on capital employed | -11.61% |
liquidity ratios | |
|---|---|
| current ratio | 3.74 |
| quick ratio | 3.71 |
| cash ratio | 0.71 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 32.62 |
| operating cycle | 112.58 |
| days of payables outstanding | 172.19 |
| cash conversion cycle | -59.61 |
| receivables turnover | 4.57 |
| payables turnover | 2.12 |
| inventory turnover | 11.19 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -23.31 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.73 |
| cash per share | 9.05 |
| operating cash flow per share | -0.38 |
| free cash flow operating cash flow ratio | 1.92 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1.09 |
Frequently Asked Questions
When was the last time Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) reported earnings?
Tarsus Pharmaceuticals, Inc. (TARS) published its most recent earnings results on 06-05-2026.
What is Tarsus Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)'s trailing twelve months ROE is -14.19%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tarsus Pharmaceuticals, Inc. (TARS) currently has a ROA of -8.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TARS's net profit margin stand at?
TARS reported a profit margin of -9.02% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TARS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.74 in the most recent quarter. The quick ratio stood at 3.71, with a Debt/Eq ratio of 0.00.